Boris Kablar

Prof. Dr. Boris Kablar

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2003 in Developmental Biology
Verified
Journal Article
Closed access
BKBoris Kablar
Boris Kablar
KKKirsten Krastel
Kirsten Krastel
STShahragim Tajbakhsh
Shahragim Tajbakhsh
MRMichael Rudnicki
Michael Rudnicki

6 October 2005 in Wilhelm Roux' Archiv für Entwicklungsmechanik der Organismen
Verified
Journal Article
Closed access
PDF file
IRIrena Rot-Nikcevic
Irena Rot-Nikcevic
TRTyler Reddy
Tyler Reddy
KDKevin J. Downing
Kevin J. Downing
ABAnne C. Belliveau
Anne C. Belliveau
BHBenedikt Hallgrimsson
Benedikt Hallgrimsson
BKBoris Kablar
Boris Kablar

21 January 2008 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
MBMark Baguma‐Nibasheka
Mark Baguma‐Nibasheka
BKBoris Kablar
Boris Kablar
Connective tissue growth factor (CTGF) is a mediator of growth factor activity, and Ctgf knockouts die at birth from respiratory failure due to skeletal dysplasia. Previous microarray analysis revealed Ctgf down‐regulation in the hypoplastic lungs of amyogenic mouse embryos. This study, therefore, examined pulmonary development in Ctgf−/− mouse fetuses to investigate if respiration could also have been impaired by lung abnormalities. The Ctgf−/− lungs were hypoplastic, with reduced cell proliferation and increased apoptosis. PDGF‐B, its receptor and IGF‐I, were markedly attenuated and the TTF‐1 gradient lost. Type II pneumocyte differentiation was perturbed, the cells depicting excessive glycogen retention and diminished lamellar body and nuclear size, though able to synthesize surfactant‐associated protein. However, type I pneumocyte differentiation was not affected by Ctgf deletion. Our findings indicate that the absence of Ctgf and/or its protein product, CTGF, may induce pulmonary hypoplasia by both disrupting basic lung developmental processes and restricting thoracic expansion. Developmental Dynamics 237:485–493, 2008.

1 January 2007
Verified
Journal Article
Closed access
IRI. Rot-Nikcevic
I. Rot-Nikcevic
KDK. J. Downing
K. J. Downing
BHB. K. Hall
B. K. Hall
BKBoris Kablar
Boris Kablar

20 April 2005 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
MIMohammad Reza Inanlou
Mohammad Reza Inanlou
BKBoris Kablar
Boris Kablar
In the current study, the role of contractile activity of respiratory muscles in fetal lung growth and cell differentiation was examined using Myf5−/−:MyoD−/− mouse embryos. As previously found, Myf5−/−:MyoD−/− mouse embryos had no respiratory musculature. Consequently, they suffered from pulmonary hypoplasia and died shortly after birth. The hypoplastic lung had decreased proliferation and increased apoptotic index as early as embryonic day 14.5. By contrast, only at the last gestational day, the number of lung cells expressing platelet derived growth factor B and insulin growth factor I was decreased, while the gradient of the thyroid transcription factor 1 was not maintained. Type II pneumocytes had a failure in glycogen utilization and surfactant storage and secretion but were able to synthesize the surfactant‐associated proteins. Type I pneumocytes were readily detectable using an early differentiation marker (i.e., Gp38). However, the late differentiation of type I pneumocytes never occurred, as revealed by transmission electron microscopy. Together, our findings suggest that pulmonary distension due to fetal breathing‐like movements plays an important role not only in lung growth but also in lung cell differentiation. Developmental Dynamics 233:772–782, 2005.

18 October 2005 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
BKBoris Kablar
Boris Kablar
ABAnne C. Belliveau
Anne C. Belliveau
To determine which combination of skeletal muscle‐derived neurotrophic factors may be important for the survival of specific subpopulations of developing spinal cord motor neurons, we used Myf5 and MyoD (myogenic regulatory factors) knockouts, containing differentially committed myogenic precursor cells (MPCc) and immunohistochemistry against several muscle‐secreted neurotrophic factors. At the peak of motor neuron cell death, skeletal muscle development is delayed in the back and body wall muscles of Myf5−/− embryos and in the limb muscles of MyoD−/− embryos. We hypothesized that, if the skeletal muscle was indeed an important source of survival factors for motor neurons, the back, the abdominal wall, and the forelimb MPCs of Myf5−/− or MyoD−/− embryos should produce at least some neurotrophic factors necessary for the survival of motor neurons. In this report, we demonstrate that (1) different MPCs lacking Myf5, MyoD, or Myf5/MyoD have different capabilities in providing factors potentially required for the survival of motor neurons and intramuscular nerve branching, (2) MPCs in double‐mutant embryos do not contain neurotrophic factors in the absence of myogenic specification, and (3) different subpopulations of MPCs contain different combinations of neurotrophic factors potentially required for the survival of the specific subpopulations of innervating motor neurons. Developmental Dynamics 234:659–669, 2005.